• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1995 Fiscal Year Final Research Report Summary

Isolation and amplification of residural normal stem cells from bone maurow of clonal hemopoietic disorders

Research Project

Project/Area Number 06807088
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Hematology
Research InstitutionNagoya University

Principal Investigator

HOTTA Tomomitsu  Nagoya Univ, Medicine, Associate Prof, 医学部, 講師 (70173606)

Co-Investigator(Kenkyū-buntansha) 木下 朝博  名古屋大学, 医学部, 医員
MURATE T  Nagoya Univ, Medicine, Research Assistant, 医学部, 助手 (30239537)
KINOSHITA T  Nagoya Univ, Medicine, clin, fellow
Project Period (FY) 1994 – 1995
Keywordsstem cell / clonality / hemopoietic colony / X-chromosome / HUMARA gene
Research Abstract

We analyzed the clonality of hemopoietic progenitor cells in bone marrow failure including myelody splastic syndromes (MDS) and aplastic anemia using X-chromosome inactivation and the RFLP of phosphogly cerate kinase (PGK) gene or the heterogeneity of short tandem repeat of CAG sequence in human androgen receptor gene (HUMARA) in female patients. CD34-positive bone marrow cells were cultured in methylcellrose medium supplemented with EPO,GM-CSF and SCF for 14 days. Individual colonies were picked-up under an inverted microscope. Extracted DNA was divided into two parts. One was digested with methylation-sensitive enzyme Hha 1 and the other remained undigested. The resulting DNA were amplified by PCR using PGK or HUMARA primers. PCR products were electrophoresed in polyacrylamide gel. In the present study we demonstrated residual non-clonal progenitor pupulations in bone marrow of most MDS patients. According to the results of residual normal progenitors in MDS we treated the patients with chemotherapy and confirmed the recovery of nonclonal hemopoiesis at remission of the disease. These results strongly suggested that isolation and amplification of residual normal progenitors permit us to develop a new treatment strategy for MDS.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] Asano H,Hotta T,et al: "Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes" Blood. 84. 588-594 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ito,T,Hotta.T,et al: "Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemothenagy" Leukemia. 8. 839-843 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hotta T,Ito T.Ohashi H et al: "Myelodysplastic Syndromes;Aduances in Research and Treatment" Elsevier Science B.V., 413 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Asano H,Hotta T,et al: "Evidence fornonclonal hematopoietic progenitor cell populations in bone marrow of patients with rnyelo dysplastic syndroms" Blood. 84. 588-594 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ito T,Hotta T,et al: "Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy" Leukemia. 8. 839-843 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hotta T,Ito T,Ohashi H,et al: "Clonality change after successful treatment with low-dose Ara-C in patients with myelodysplastic syndromes" Myelodysplastic Syndromes ; Advance in Research and Treatment. Elsevier Science B.V.389-393 (1995)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1997-03-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi